FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma

FAP-targeted radionuclide therapy with [¹⁷⁷Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma

Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1767-1769. doi: 10.1007/s00259-021-05634-3. Epub 2021 Dec 8.

Kaili Fu^#^{1

2

3}, Yizhen Pang^#², Liang Zhao³, Limei Lin³, Hua Wu², Long Sun², Qin Lin⁴, Haojun Chen⁵

¹ Department of Oncology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
² Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
³ Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
⁴ Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China. linqin05@163.com.
⁵ Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China. leochen0821@foxmail.com.

^# Contributed equally.

No abstract available